Free Trial
NASDAQ:RAIN

Rain Oncology Q3 2023 Earnings Report

Rain Oncology EPS Results

Actual EPS
-$0.19
Consensus EPS
-$0.27
Beat/Miss
Beat by +$0.08
One Year Ago EPS
N/A

Rain Oncology Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Rain Oncology Announcement Details

Quarter
Q3 2023
Time
N/A
Conference Call Date
Thursday, November 9, 2023
Conference Call Time
4:00PM ET

Rain Oncology Earnings Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
See More Rain Oncology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rain Oncology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rain Oncology and other key companies, straight to your email.

About Rain Oncology

As of January 26, 2024, operates as a subsidiary of Pathos AI, Inc.

View Rain Oncology Profile

More Earnings Resources from MarketBeat